These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 14677681)

  • 21. Immunisation of cattle with a recombinant vaccinia vector expressing the haemagglutinin gene of rinderpest virus.
    Yamanouchi K; Inui K; Sugimoto M; Asano K; Nishimaki F; Kitching RP; Takamatsu H; Barrett T
    Vet Rec; 1993 Feb; 132(7):152-6. PubMed ID: 8456545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein.
    Walsh EP; Baron MD; Anderson J; Barrett T
    J Gen Virol; 2000 Mar; 81(Pt 3):709-18. PubMed ID: 10675408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of a monoclonal antibody based competitive enzyme-linked immunosorbent assay for the detection of rinderpest virus antibodies.
    Singh RP; Sreenivasa BP; Dhar P; Roy RN; Bandyopadhyay SK
    Rev Sci Tech; 2000 Dec; 19(3):754-63. PubMed ID: 11107618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of vaccinal protection against rinderpest in Cameroon. III. General evaluation].
    Ngangnou A; Zoyem N; Hamet M; Abdoulkadiri S
    Rev Elev Med Vet Pays Trop; 1996; 49(1):18-22. PubMed ID: 8881414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in the development of a heat-stable recombinant rinderpest vaccine using an attenuated vaccinia virus vector.
    Yamanouchi K; Barrett T
    Rev Sci Tech; 1994 Sep; 13(3):721-35. PubMed ID: 7949348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a thermoresistant tissue culture rinderpest vaccine virus.
    Raut A; Singh RK; Malik M; Joseph MC; Bakshi CS; Suryanarayana VV; Butchaiah G
    Acta Virol; 2001; 45(4):235-41. PubMed ID: 11885930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of new generation rinderpest vaccines.
    Barrett T; Parida S; Mohapatra M; Walsh P; Das S; Baron MD
    Dev Biol (Basel); 2003; 114():89-97. PubMed ID: 14677680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Attenuation of a strain of rinderpest virus: potential homologous live vaccine].
    Diallo A; Taylor WP; Lefèvre PC; Provost A
    Rev Elev Med Vet Pays Trop; 1989; 42(3):311-9. PubMed ID: 2485537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rinderpest eradication: appropriate technology and social innovations.
    Mariner JC; House JA; Mebus CA; Sollod AE; Chibeu D; Jones BA; Roeder PL; Admassu B; van 't Klooster GG
    Science; 2012 Sep; 337(6100):1309-12. PubMed ID: 22984063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive enzyme-linked immunosorbent assay based on monoclonal antibody and recombinant hemagglutinin for serosurveillance of rinderpest virus.
    Renukaradhya GJ; Suresh KB; Rajasekhar M; Shaila MS
    J Clin Microbiol; 2003 Mar; 41(3):943-7. PubMed ID: 12624013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and expression of the nucleocapsid gene of virulent Kabete O strain of rinderpest virus in baculovirus: use in differential diagnosis between vaccinated and infected animals.
    Ismail T; Ahmad S; D'Souza-Ault M; Bassiri M; Saliki J; Mebus C; Yilma T
    Virology; 1994 Jan; 198(1):138-47. PubMed ID: 8259649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a N gene-based PCR-ELISA for detection of Peste-des-petits-ruminants virus in clinical samples.
    Saravanan P; Singh RP; Balamurugan V; Dhar P; Sreenivasa BP; Muthuchelvan D; Sen A; Aleyas AG; Singh RK; Bandyopadhyay SK
    Acta Virol; 2004; 48(4):249-55. PubMed ID: 15745048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rinderpest: at war with the disease of war.
    Crowther JR
    Sci Prog; 1997; 80 ( Pt 1)():21-43. PubMed ID: 9161126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Feasibility study on global peste des petits ruminants eradication based on rinderpest eradication].
    Liu FX; Liu ZS; Wang ZL
    Bing Du Xue Bao; 2012 Jan; 28(1):89-96. PubMed ID: 22416357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with veterinary vaccines in warm climates.
    Tulasne JJ; Lefèvre PC; Blancou J
    Dev Biol Stand; 1996; 87():33-42. PubMed ID: 8854000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in the diagnosis of rinderpest and peste des petits ruminants.
    Diallo A; Libeau G; Couacy-Hymann E; Barbron M
    Vet Microbiol; 1995 May; 44(2-4):307-17. PubMed ID: 8588326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and oral immunogenicity of hemagglutinin protein of rinderpest virus expressed by transgenic peanut plants in a mouse model.
    Khandelwal A; Renukaradhya GJ; Rajasekhar M; Sita GL; Shaila MS
    Virology; 2004 Jun; 323(2):284-91. PubMed ID: 15193924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine.
    Ngichabe CK; Wamwayi HM; Ndungu EK; Mirangi PK; Bostock CJ; Black DN; Barrett T
    Epidemiol Infect; 2002 Apr; 128(2):343-9. PubMed ID: 12002554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.